Explanipedia

Navigating Severe Thrombocytopenia in End-Stage Liver Disease: A Pre-transplant Management Dilemma Open

Fares Jamal, Amani Elshaer, Cody Eslinger, Sailendra Naidu, Rolland C. Dickson , et al. · 2025

Hepatitis B reactivation after solid organ transplantation: A single-center experience Open

Josiah D. McCain, Rolland C. Dickson, Jacqueline Cai, Nan Zhang, Surakit Pungpapong , et al. · 2024

The risk of HBV reactivation after solid organ transplantation and the strategies to prevent it are not well defined. We reviewed patients who received liver, kidney, pancreas, or heart transplants at our center between September 2015 and …

Optimizing Palliative Medicine Support for Liver Transplant Candidates Open

Richard Guthrie, Rolland C. Dickson, David M. Chascsa, Matthew Martin, Beth Perry , et al. · 2024

Hepatitis C–Seropositive Liver Transplants: A Multimethod Study to Evaluate Protocol Implementation Open

Matthew Martin, Sherilyn A. Faulkner, Yash Suri, Bashar Aqel, Surakit Pungpapong , et al. · 2022

Background: Starting in November 2017, 3 liver transplant centers in a single health care system tested and implemented a new protocol to begin accepting livers from hepatitis C virus–seropositive donors for seronegative liver transplant r…

Exogenous copper exposure causing clinical wilson disease in a patient with copper deficiency Open

Blanca Lizaola‐Mayo, Rolland C. Dickson, Dora Lam‐Himlin, David M. Chascsa · 2021

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C Open

Chung Sang Tse, Ju Dong Yang, Omar Y. Mousa, Kevin M. Nelson, Surakit Pungpapong , et al. · 2020

Background: Direct-acting antivirals (DAA) are highly effective for the treatment of hepatitis C (HCV), although there are limited data on the safety and efficacy of DAA therapy in hepatitis C-positive individuals awaiting liver transplant…

Hepatitis C Testing and Liver Fibrosis Predictors in the Birth Cohort of a Primary Care Practice Open

Sophie Bersoux, Lanyu Mi, Bashar Aqel, Rolland C. Dickson · 2020

The Epidemiology and Clinical Associations of Portal Vein Thrombosis in Hospitalized Patients With Cirrhosis: A Nationwide Analysis From the National Inpatient Sample Open

Shawn L. Shah, Joseph C. Anderson, Joseph J. Shatzel, Arifa Toor, Rolland C. Dickson · 2017

P2][3] The risk of developing PVT in patients with cirrhosis has been correlated with the severity of hepatic impairment. 4,5There is a lack of national-level data on the epidemiology of PVT and its related outcomes in the inpatient settin…

814 The Epidemiology and Clinical Associations of Portal Vein Thrombosis in Hospitalized Cirrhotic Patients: A Nationwide Analysis from the National Inpatient Sample Open

Shawn Shah, Bharat Maraj, Rolland C. Dickson, Arifa Toor, Amreen Dinani · 2016

Quelling Inflammation with Ketosis and Steric Chemistry Open

Michael Gleeson, Rolland C. Dickson · 2016

Exploring the clinical relationship of diet and inflammatory disorders of the gastrointestinal tract has been a challenging landscape of investigation.1 Recent studies have shed light on the contribution of specific carbohydrates to fat ac…

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection Open

Mark Sulkowski, Hugo E. Vargas, Adrian M. Di Bisceglie, Alexander Kuo, K. Rajender Reddy , et al. · 2015

Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single‐center retrospective cohort study Open

Joseph J. Shatzel, Parambir S. Dulai, Devin E. Harbin, Henry Cheung, Thomas Reid , et al. · 2015

Albumin Gains Immune Boosting Credibility Open

Michael Gleeson, Rolland C. Dickson · 2015

Albumin has long been used as a clinical intervention for renal protection in our patients with decompensated cirrhosis.1 Numerous studies have demonstrated the clinical utility of albumin in hepatorenal syndrome and spontaneous bacterial …

Rolland C. Dickson YOU? Author Swipe